Aslan Fred (CIK 1909362) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-15). Recent activity: Buy ARTV (110,000 shares), Buy ARTV (45,000 shares), Sell ARTV (23,429 shares), Sell ARTV (61,888 shares), Sell ARTV (27,116 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-15 | Artiva Biotherapeutics, Inc. (ARTV) | Chief Executive Officer | Buy | 110,000 | $0 |
| 2026-09-14 | Artiva Biotherapeutics, Inc. (ARTV) | Chief Executive Officer | Buy | 45,000 | $0 |
| 2026-09-09 | Artiva Biotherapeutics, Inc. (ARTV) | Chief Executive Officer | Sell | 23,429 | $255,746 |
| 2026-09-04 | Artiva Biotherapeutics, Inc. (ARTV) | Chief Executive Officer | Sell | 61,888 | $690,392 |
| 2026-05-19 | Artiva Biotherapeutics, Inc. (ARTV) | Chief Executive Officer | Sell | 27,116 | $244,315 |
| 2026-02-18 | Artiva Biotherapeutics, Inc. (ARTV) | President and CEO | Buy | 366,850 | $0 |
| 2026-02-18 | Artiva Biotherapeutics, Inc. (ARTV) | President and CEO | Sell | 14,600 | $58,400 |
| 2025-12-15 | Artiva Biotherapeutics, Inc. (ARTV) | President and CEO | Sell | 3,187 | $19,122 |
| 2025-12-12 | Artiva Biotherapeutics, Inc. (ARTV) | President and CEO | Buy | 869,136 | $0 |
| 2025-11-17 | Artiva Biotherapeutics, Inc. (ARTV) | President and CEO | Sell | 6,347 | $20,628 |
| 2025-11-17 | Artiva Biotherapeutics, Inc. (ARTV) | President and CEO | Sell | 6,375 | $21,548 |
| 2025-10-17 | Artiva Biotherapeutics, Inc. (ARTV) | President and CEO | Sell | 25,500 | $153,000 |
| 2025-08-18 | Artiva Biotherapeutics, Inc. (ARTV) | President and CEO | Sell | 4,472 | $9,525 |
| 2025-08-18 | Artiva Biotherapeutics, Inc. (ARTV) | President and CEO | Sell | 25,500 | $69,615 |
| 2025-08-18 | Artiva Biotherapeutics, Inc. (ARTV) | President and CEO | Sell | 4,472 | $12,298 |
来源：SEC Form 4 申报文件 · 截至 2026-09-15